King's College London

Research portal

Predicting Biopsy Outcomes During Active Surveillance for Prostate Cancer: External Validation of the Canary Prostate Active Surveillance Study Risk Calculators in Five Large Active Surveillance Cohorts

Research output: Contribution to journalArticle

The Movember Foundations Global Action Plan Prostate Cancer Active Surveillance (GAP) Consortium

Original languageEnglish
Pages (from-to)693-702
Number of pages10
JournalEuropean Urology
Volume76
Issue number5
DOIs
Publication statusPublished - 1 Nov 2019

King's Authors

Abstract

Two active surveillance risk calculators to predict disease reclassification on prostate biopsy are externally validated by the Movember Foundation's Global Action Plan (GAP3) consortium. They proved to be clinically useful and could reduce unnecessary biopsies, but need recalibration to local settings.

View graph of relations

© 2018 King's College London | Strand | London WC2R 2LS | England | United Kingdom | Tel +44 (0)20 7836 5454